Cutaneous Mucormycosis Following a Bullous Pemphigoid Flare in a Chronic Lymphocytic Leukemia Patient on Ibrutinib

While the recent development of novel therapeutics in oncology, such as small molecule kinase inhibitors (SMKIs), has enabled our ability to target disease-specific molecular pathways, the prolonged impact of these agents on the immune system and infectious risk remains to be seen. We present a 68-y...

Descripción completa

Detalles Bibliográficos
Autores principales: Stein, Matthew K., Karri, Saradasri, Reynolds, Jackson, Owsley, Jeff, Wise, Austin, Martin, Mike G., Zare, Fereshteh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942210/
https://www.ncbi.nlm.nih.gov/pubmed/29760835
http://dx.doi.org/10.14740/wjon1099w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942210/
https://www.ncbi.nlm.nih.gov/pubmed/29760835
http://dx.doi.org/10.14740/wjon1099w

Ejemplares similares